Intraparenchymal haemorrhages as a primary outcome measure - Authors' reply
Lancet Neurol
.
2021 Aug;20(8):595-596.
doi: 10.1016/S1474-4422(21)00184-8.
Authors
Benjamin Maïer
1
,
Jean-Philippe Desilles
1
,
Mikael Mazighi
2
;
BP-TARGET Investigators
Affiliations
1
Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France; Department of Neurology, Université de Paris, Paris, France; FHU Neurovasc, Paris, France; INSERM U1148, Laboratory of Vascular Translational Science, Paris, France.
2
Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France; Department of Neurology, Université de Paris, Paris, France; FHU Neurovasc, Paris, France; INSERM U1148, Laboratory of Vascular Translational Science, Paris, France. Electronic address: mmazighi@for.paris.
PMID:
34302779
DOI:
10.1016/S1474-4422(21)00184-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Hemorrhage*
Humans
Outcome Assessment, Health Care*